X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
DR. REDDY'S LABORATORIES LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

DR. REDDY'S LABORATORIES LIMITED   (REDY)


Here is the latest financial fact sheet of Dr. Reddys. For more details, see the Dr. Reddys quarterly results and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
dr. reddys lab - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 2,645.7       No. of shares m 165.71
    Mkt Cap Rs m 438,419       % ch % 1.4
    Vol '000 13.3       % ch week % 0.6
    P/E X 42.6       % ch 1-mth % 0.3
    P/CF X 14.0       % ch 12-mth % -15.2
    EPS (TTM) Rs 62.1       52 week H/L Rs 3,689.0/2,560.0
(As on Apr 25, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs1,7711,9692,9403,6624,383 
Low Rs1,3871,5281,7662,2502,750 
Sales per share (Unadj.) Rs578.8700.4788.6881.8920.1 
Earnings per share (Unadj.) Rs76.789.9115.4137.1126.1 
Diluted earnings per shareRs78.592.1118.5141.0129.8 
Cash flow per share (Unadj.) Rs107.3122.3153.5181.7183.0 
Dividends per share (Unadj.) Rs13.7515.0018.0020.0020.00 
Adj. dividends per shareRs14.0715.3718.4820.5620.59 
Dividend yield (eoy) %0.90.90.80.70.6 
Book value per share (Unadj.) Rs294.2375.0462.4578.3685.8 
Adj. book value per shareRs301.1384.4474.6594.6706.1 
Shares outstanding (eoy) m169.56169.84170.11170.38170.61 
Bonus/Rights/Conversions  ESOPESOPESOPESOPESOP 
Price / Sales ratio x2.72.53.03.43.9 
Avg P/E ratio x20.619.520.421.628.3 
P/CF ratio (eoy) x14.714.315.316.319.5 
Price / Book Value ratio x5.44.75.15.15.2 
Dividend payout %17.916.715.614.615.9 
Avg Mkt Cap Rs m267,735296,965400,277503,643608,481 
No. of employees `00015.016.519.019.921.7 
Total wages/salary Rs m15,91219,28724,75429,44631,874 
Avg. sales/employee Rs Th6,543.07,209.57,060.77,565.77,244.4 
Avg. wages/employee Rs Th1,060.81,168.91,302.81,482.91,470.9 
Avg. net profit/employee Rs Th867.3925.31,033.31,176.6992.8 
  INCOME DATA
Net Sales Rs m98,145118,956134,153150,233156,978 
Other income Rs m1,3231,4991,6972,7412,693 
Total revenues Rs m99,468120,455135,850152,974159,671 
Gross profit Rs m24,31127,19532,50834,93634,587 
Depreciation Rs m5,1815,5026,4757,5999,705 
Interest Rs m1,0561,0031,2671,082824 
Profit before tax Rs m19,39722,18926,46328,99626,751 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m-1,353-542000 
Tax Rs m5,0356,3796,8315,6325,237 
Profit after tax Rs m13,00915,26819,63223,36421,514 
Gross profit margin %24.822.924.223.322.0 
Effective tax rate %26.028.725.819.419.6 
Net profit margin %13.312.814.615.613.7 
  BALANCE SHEET DATA
Current assets Rs m69,99085,267103,257118,767118,201 
Current liabilities Rs m45,91456,58857,90468,21368,368 
Net working cap to sales %24.524.133.833.731.7 
Current ratio x1.51.51.81.71.7 
Inventory Days Days7267666260 
Debtors Days Days94989010097 
Net fixed assets Rs m41,20246,15952,79659,06072,265 
Share capital Rs m848849851852853 
"Free" reserves Rs m43,67756,36472,94692,735111,548 
Net worth Rs m49,89063,69178,65298,531117,009 
Long term debt Rs m16,41912,65920,75514,31510,690 
Total assets Rs m111,902134,872160,296185,978200,104 
Interest coverage x19.423.121.927.833.5 
Debt to equity ratio x0.30.20.30.10.1 
Sales to assets ratio x0.90.90.80.80.8 
Return on assets %12.612.113.013.111.2 
Return on equity %26.124.025.023.718.4 
Return on capital %28.829.727.926.721.6 
Exports to sales %49.351.355.249.446.3 
Imports to sales %9.49.78.99.09.0 
Exports (fob) Rs m48,40561,00474,05974,14672,618 
Imports (cif) Rs m9,19911,48711,95913,48514,050 
Fx inflow Rs m49,36764,29076,00774,87075,405 
Fx outflow Rs m15,29220,12524,60726,00827,115 
Net fx Rs m34,07544,16551,40048,86248,290 
  CASH FLOW
From Operations Rs m 16,126 13,779 19,697 25,235 40,476 
From Investments Rs m -18,884 -14,463 -16,941 -22,647 -19,421 
From Financial Activity Rs m 3,891 -1,568 -242 -4,332 -17,009 
Net Cashflow Rs m 1,133 -2,252 2,514 -1,744 4,046 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for dr. reddy's laboratories limited

 Share Holding
Indian Promoters : 25.5%
Foreign collaborators : 0.0%
Indian inst/Mut Fund : 5.4%
FIIs : 35.3%
ADR/GDR : 18.5%
Free float : 15.3%
Shareholders : 75,885
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034
    E-MAIL: spoddar@drreddys.com     WEB: www.drreddys.com
    TELEPHONE: (040) 4900 2222     FAX: (040) 4900 2999
    SECTOR: PHARMACEUTICALS     GROUP: Dr. Reddy's Group
    TR AGENT: Bigshare Services Ltd., G-10, Left wing, Amrutha Ville, Hyderabad - 82
    AUDITOR: B. S. R & Co.
CHM: G. V. Prasad COMP SEC: Sandeep Poddar YEAR OF INC: 1984 BSE CODE: 500124 FV (Rs): 5 DIV YIELD (%): 0.8

More pharmaceuticals Company Fact Sheets:   WYETH LTDTTK HEALTHCAREPANACEA BIOTECHALKEM LABORATORIESTORRENT PHARMA


Today's Market

Markets Finish Strong; Nifty Closes at All Time High(Closing)

Indian share markets continued to witness buying momentum in the afternoon session fueled by a rally in Reliance Industries and other blue chips on upbeat earnings.

Views on news

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

More Views on News

Most Popular

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

Aur Bhi Dukh Hain Zamane Main Stock Market Ke Siva...(Vivek Kaul's Diary)

Apr 13, 2017

The link between the Indian economy and the stock market is weak, and the stock market is not a reflection of the Indian economy.

The Real Reason Indiabulls Real Estate Jumped 42%(Daily Profit Hunter)

Apr 19, 2017

An elephant and six blind men will tell you more about the markets than any financial newspaper or channel.

7 Benefits Of Creating A CAN(Outside View)

Apr 13, 2017

The MFU platform offers ease, convenience, and speed of transacting in various mutual fund schemes.

More

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB 8-QTR ANALYSIS

Detailed Quarterly Results With Charts

COMPARE DR. REDDYS LAB WITH

MARKET STATS